Statistical methods in psychiatry & mental health trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Mixed-effects model
MMRM (mixed model for repeated measures)
Multiple imputation / missing data
Cochran-Mantel-Haenszel test
Odds ratio
t-test
Logistic regression
All psychiatry & mental health trials
732 results
- Bryostatin Treatment of Moderately Severe Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Bryostatin Treatment of Moderately Severe Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04538066).
- Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Building and Pilot Testing a Couples-based Smartphone Systems to Address Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: Complete Statistical AnalysisIndependent statistical analysis of Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00879996).
- Buspirone Therapy for Localized Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Buspirone Therapy for Localized Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01496612).
- BWP-ADIndependent statistical analysis of Enhancing Consent for Alzheimer's Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00453544).
- C-RESULTSIndependent statistical analysis of Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03737318).
- CAFIndependent statistical analysis of Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CAMMPSIndependent statistical analysis of Comprehensive vs. Assisted Management of Mood and Pain Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01757301).
- CAMPIndependent statistical analysis of the CAMP trial comparing antipsychotic treatment strategies for metabolic problems in schizophrenia or schizoaffective disorder, including its randomized design, non-HDL cholesterol endpoint, mixed-effects analysis, and reported safety data.
- CAN QuitIndependent statistical analysis of Connecting Alaska Native People to Quit Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03645941).
- Cannabidiol in Youth Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Cannabidiol in Youth Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05317546).
- Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00588731).
- Cannabinoids for Pain Control During Medical Abortion: Complete Statistical AnalysisIndependent statistical analysis of Cannabinoids for Pain Control During Medical Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03604341).
- Cannabis for Spasticity in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Cannabis for Spasticity in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00682929).
- CAP’ONCOIndependent statistical analysis of CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults: Complete Statistical AnalysisIndependent statistical analysis of Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Care Partner Assisted Intervention to Improve Oral Health of Individuals With Mild Dementia: Complete Statistical AnalysisIndependent statistical analysis of Care Partner Assisted Intervention to Improve Oral Health of Individuals With Mild Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Caregiver SOSIndependent statistical analysis of Caregiver Self-Management of Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337021).
- CARES: A Mobile Health Program for Alcohol Risk Reduction: Complete Statistical AnalysisIndependent statistical analysis of CARES: A Mobile Health Program for Alcohol Risk Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03927482).
- CARTERIndependent statistical analysis of Circuitry Assessment and Reinforcement Training Effects on Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04290988).
- CATIEAn independent statistical analysis and educational interpretation of CATIE, a phase 4 randomized double-blind crossover trial evaluating multiple antipsychotic interventions in schizophrenia.
- Caverject User Study: Complete Statistical AnalysisIndependent statistical analysis of Caverject User Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01008605).
- CBDIndependent statistical analysis of Cannabidiol Treatment in Patients With Early Psychosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02504151).
- CBT-AIndependent statistical analysis of Group CBT for Aggression in Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02233517).
- CBTi GWIIndependent statistical analysis of Cognitive Behavioral Therapy for Insomnia for Gulf War Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02782780).
- CHALLENGEIndependent statistical analysis of Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer: primary endpoint results, effect estimate…
- Chamomile for Chronic Primary Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Chamomile for Chronic Primary Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01286324).
- Chantix for Treating Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Chantix for Treating Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00567008).
- Characteristics of Sleep Patterns in Young Adults With and Without Insomnia: Complete Statistical AnalysisIndependent statistical analysis of Characteristics of Sleep Patterns in Young Adults With and Without Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CHOICESIndependent statistical analysis of Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Chronic Sleep Deprivation Among the Poor: A Lab-in-the-field Approach: Complete Statistical AnalysisIndependent statistical analysis of Chronic Sleep Deprivation Among the Poor: A Lab-in-the-field Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03322358).
- Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM): Complete Statistical AnalysisIndependent statistical analysis of Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cigarette Pack Inserts for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Cigarette Pack Inserts for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04075682).
- Cigarillo Warnings Image Sorting Study: Complete Statistical AnalysisIndependent statistical analysis of Cigarillo Warnings Image Sorting Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05838378).
- Circadian Effects of Escitalopram: Complete Statistical AnalysisIndependent statistical analysis of Circadian Effects of Escitalopram: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01214044).
- CJC-TraCIndependent statistical analysis of Criminal Justice Coordinated Transitional Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05376371).
- Clarithromycin for the Treatment of Hypersomnia: Complete Statistical AnalysisIndependent statistical analysis of Clarithromycin for the Treatment of Hypersomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01146600).
- CLARITY ADIndependent statistical analysis of the phase 3 CLARITY AD trial of lecanemab in participants with early Alzheimer's disease, covering trial design, CDR-SB endpoints, safety endpoints, planned statistical analysis, and interpretation.
- Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry: Complete Statistical AnalysisIndependent statistical analysis of Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Clinical Trial of CNS-targeted HAART (CIT2): Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of CNS-targeted HAART (CIT2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624195).
- Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children: Complete Statistical AnalysisIndependent statistical analysis of Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COCOVIndependent statistical analysis of Care Outcomes for Chiropractic Outpatient Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03254719).
- Cognition Platform Study in Participants at Risk for Alzheimer’s Disease (AD) (MK-0000-413): Complete Statistical AnalysisIndependent statistical analysis of Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00108628).
- Cognitive Enhancement Through Computerized Training: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Enhancement Through Computerized Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04244032).
- Cognitive Remediation for Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01393457).
- Cognitive Remediation With D-Cycloserine: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation With D-Cycloserine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01399866).
- Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05860127).